Dr. Alek Adkins is an Assistant Professor of Emergency Medicine and Pediatrics at The Ohio State University. He is currently one of the Medical Toxicologists with the Central Ohio Poison Center and Nationwide Children’s Hospital. He also serves as an attending physician with The Ohio State University Wexner Medical Center Department of Emergency Medicine. Dr. Adkins got his undergraduate degree in Biochemistry from High Point University in High Point, North Carolina. He graduated medical school from The Ohio State University College of Medicine, and completed his Emergency Medicine Residency at ChristianaCare in Newark, DE. After residency, he completed his Medical Toxicology fellowship at UPMC in Pittsburgh, PA. He is currently board certified in Emergency Medicine and Medical Toxicology. Dr. Adkins’ interests include addiction medicine, acute inpatient toxicology, and systems-based delivery methods for antidotal therapy.

Dr. Arens is an Emergency Medicine physician who practices at Ochsner Medical Center in New Orleans, LA. Dr. Arens completed her Emergency Medicine training at the Denver Health Residency in Emergency Medicine, and her medical toxicology training at the University of California – San Francisco. She was amongst the first toxicologists to identify and describe counterfeit fentanyl products, and has continued to identify outbreaks of new drugs of abuse. She has a broad range of research interests including: the identification of new drugs of abuse including novel opioids contributing to the current opioid epidemic, the use of antidotes, and advanced supportive care of the poisoned patient.

Dr. Berenji is a double board certified physician specializing in Occupational and Environmental Medicine as well as Preventive Medicine. She is currently Chief of Occupational Health at VA Long Beach Healthcare System. She also leads the Environmental Health Clinic at VA Long Beach Healthcare System, conducting exposure assessments for veterans (including Agent Orange, Gulf War, and Open Burn Pit registry exams). She is Clinical Assistant Professor in the Department of Occupational and Environmental Medicine at UC Irvine School of Medicine as well as Clinical Assistant Professor in the Department of Environmental and Occupational Health in Program in Public Health, Susan and Henry Samueli College of Health Sciences. She is currently pursuing board eligibility in Clinical Informatics through the Practice Pathway. She is Vice Chair of the Health Informatics section of the American College of Occupational and Environmental Medicine and she is currently spearheading the Presidential Task Force on Digital Transformation through a Planetary Health Lens. She is affiliated with the University of California Center for Climate, Health and Equity, where she is leading efforts to enhance academic society partnerships; integrating data systems to enhance emergency preparedness surrounding climate-related events; working with community leaders on climate solutions; and developing climate curricula for medical students and residents. She is also a certified medico-legal evaluator and qualified medical examiner in the state of California.

Jeremy Berger, DO, MPH, MS, Lt Col, MC (FS), USAF, is a physician and first-year resident in the Occupational and Environmental Medicine Residency at the Harvard T.H. Chan School of Public Health. He also serves as a Postdoctoral Research Fellow in the Department of Environmental Health, where his work centers on occupational exposures, environmental hazards, and military-relevant health risks.

Dr. Berger is an active-duty U.S. Air Force flight surgeon with the rank of Lieutenant Colonel, bringing extensive operational medical experience to his research and training. His background spans preventive medicine, environmental health, and aerospace medicine, with a focus on advancing evidence-based strategies to protect worker and service member health across diverse environments.

Dr. Michele Burns is triple boarded in general pediatrics, pediatric emergency medicine, and medical toxicology. She has been the Medical Director of the Massachusetts and Rhode Island Poison Center for the last 25 years and is Chief of the Boston Children's Hospital Toxicology service. Her clinical research interests include investigating the epidemiological trends of pediatric poisoning exposures by using large hospital or national databases, and clinical communications that describe novel and innovative case presentations and/or treatment modalities in the pediatric toxicology patient. In addition, she is the Harvard Medical Toxicology Fellowship Director and a former member of both the ACMT Board and ABEM Medical Toxicology Subboard. Dr. Burns is also the Pediatric Toxicology Section Editor for UptoDate. She is committed to promoting optimal health care for acutely injured and poisoned patients, advocating for state-of-the-art treatment while contributing to national consensus guidelines and prevention efforts on a more global level.

Dr. Dazhe (James) Cao, MD, is an Associate Professor and Division Chief of Medical Toxicology in the Department of Emergency Medicine at UT Southwestern Medical Center. Dr. Cao earned his medical degree at Baylor College of Medicine. He completed a residency in emergency medicine at Carolinas Medical Center and received advanced training in medical toxicology through a fellowship at Rocky Mountain Poison & Drug Safety.  Certified by the American Board of Emergency Medicine in emergency medicine and medical toxicology, he joined the UT Southwestern faculty in 2015. Dr. Cao is the Medical Director of Toxicology for the Parkland Health & Hospital System. In addition, he is a member of the American College of Medical Toxicology, the American Academy of Clinical Toxicology, the American College of Emergency Physicians, and the Emergency Medicine Residents’ Association. Dr. Cao has delivered numerous national and regional invited lectures, contributed to the eleventh edition of the textbook Goldfrank's Toxicologic Emergencies, and published several academic articles.

Dr. Stephanie Carreiro is a physician-scientist at the forefront of digital health innovation in emergency medicine and medical toxicology. As an Associate Professor, Vice Chair of Research, and Director of the Tox(In)novation Lab at the University of Massachusetts Chan Medical School, she leads groundbreaking work that blends clinical expertise with cutting-edge technology to transform how we prevent, detect, and treat substance use disorders. Her research centers on digital phenotyping, digital therapeutics, and understanding how real-world patterns of technology use can inform interventions and promote health equity.

She earned her MD from New York Medical College in 2009, completed emergency medicine residency training at Brown University in 2013, and went on to complete a medical toxicology fellowship (2015) and a PhD in Biomedical Sciences (2022) at the University of Massachusetts. This foundation in both clinical medicine and biomedical research underpins her mission to develop practical, evidence-based digital solutions that improve patient outcomes and expand access to care.

Dr. Carreiro leads a diverse portfolio of industry-sponsored and federally funded research, including awards from the National Institute on Drug Abuse and the National Institute of Biomedical Imaging and Bioengineering. Across these projects, her goal is the same: to turn data into actionable insights, translate technology into real-world impact, and build digital tools that are as accessible as they are effective.

Dr. Peter R Chai is an associate professor of emergency medicine and medical toxicology at Brigham and Women’s Hospital/Harvard Medical School, and affiliate research scholar at the Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology, and The Fenway Institute. He is also research faculty at the Dana Farber Cancer Institute. Dr. Chai’s research primarily involves the development and implementation of technological solutions that detect and respond to changes in disease. These translational projects ranges from design of novel robotic and sensor systems in animal models to human clinical trials to test the implementation of injectable and ingestible sensor systems and overlying behavioral science architecture to respond to disease states.  Specifically, Dr. Chai is interested in applying ingestible electronic sensor systems to understand medication adherence in the context of substance use and HIV treatment/prevention. His work in developing ingestible sensors and their overlying behavioral interventions as closed loop systems to measure, reinforce and provide tools for PrEP and ART adherence has been funded by the National Institutes of Health and industry partners.

Dr. Colleen Cowdery is the Medical Director of the Washington Poison Center. She completed her Medical Toxicology fellowship at Oregon Health & Science University and the Oregon Poison Center, where she also served as a Toxicologist and Emergency Medicine Physician. Dr. Cowdery earned her medical degree from the University of Florida and completed her residency at UF Health Jacksonville. She holds a Bachelor of Arts in Ecology and Evolutionary Biology from Dartmouth College. In her current role, Dr. Cowdery oversees clinical operations, toxicology consultations, and educational initiatives, advancing the Center’s mission to provide expert guidance on poisoning and exposure management.

Dr. Curtis is a Senior Clinical Investigator and Chief of the Technology and Translational Research Section (TTRS) at NIDA Intramural Research Program. The Curtis Lab pairs traditional methodologies with computational psychiatry to study the digital phenotypes of people who use drugs. While much of the labs focus is on converting raw signals from digital data sources into useful clinical insights, the TTRS is very much committed to solving problems experienced by people in recovery and undergoing substance use treatment. Through clinical research, the Curtis lab intersects addiction treatment, computational psychiatry, and innovative technologies. Using natural-language processing, digital phenotyping, and deep learning, the lab focuses on enhancing precision assessment of substance use and behavioral predictors using intensive longitudinal data and integrating passive sensor data from smartphones and wearable devices. Among others, an overall goal is to develop personalized smartphone interventions for individuals living with SUD to enhance the recovery experience.

Dr. Erickson is an emergency medicine physician at Mass General Brigham in Boston, MA. He is the Division Chief of Medical Toxicology in the Department of Emergency Medicine. He is a Full Professor at Harvard Medical School and the Harvard Humanitarian Initiative (HHI). He is a Professor Emeritus at the University of Illinois where he established the UIC Center for Global Health. His areas of expertise include CBRNE response and training, environmental toxicology, crisis in climate change, wastewater epidemiology, and acute injuries from global conflict settings such as Ukraine, Syria, Kosovo, Sudan, and Rwanda. Over the past 3 decades he had conducted numerous projects and deployments to Ukraine with NATO and International Medical Corps (IMC).

Dr. Diana Felton is board certified in emergency medicine and medical toxicology. She has recently taken over as Chief of the Hawaii Department of Health’s Communicable Disease and Public Health Nursing Division. Prior to that, she was the State Toxicologist with the Hawaii Department of Health Hazard Evaluation and Emergency Response (HEER) Office.

She worked with many state, federal, and community partners on issues such as childhood lead poisoning prevention, safe fish consumption, air pollution risks, pesticides, and other environmental health hazards. She is a member of the Hawaii Advisory Committee on Drug Abuse and Controlled Substances and EPA’s Children’s Health Protection Advisory Committee.

She is a proud graduate of the University of California, Berkeley, attended medical school at the University of California, Davis, and completed her emergency medicine residency at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Fellowship training was completed at the Harvard Medical Toxicology Fellowship at Boston Children’s Hospital in conjunction with the Massachusetts and Rhode Island Poison Control Center.

Charlotte Goldfine, MD is an emergency medicine physician and medical toxicologist at Brigham and Women’s Hospital (BWH). She is the course director for the Harvard-Affiliated Emergency Medicine Residency toxicology core rotation and the BWH site fellowship director for the Harvard Toxicology Fellowship. Her research is focused on medication safety, medical education, and advances in digital health technologies, novel therapeutics, and drug-delivery systems in the treatment of substance use disorders.

Dr. Rose Goldman is an expert in occupational and environmental medicine with decades of experience in clinical care, faculty leadership, and public health. She serves as Faculty Advisor in the Department of Medicine at Cambridge Health Alliance and has held leadership roles including Chief of Occupational & Environmental Medicine and Director of Faculty Affairs. Dr. Goldman is board-certified in Internal Medicine and Preventive Medicine with a concentration in Occupational and Environmental Health. She has a longstanding academic appointment as Associate Professor at both Harvard Medical School and the Harvard T.H. Chan School of Public Health, where she focuses on environmental health research, education, and mentorship.

Dr. Luke Hartman is a Pediatric Emergency Medicine and Child Abuse Pediatrics fellow at Nationwide Children’s Hospital. He earned his medical degree from Ben-Gurion University of the Negev Faculty of Health Sciences in Israel and completed his pediatric residency at St. Christopher’s Hospital for Children/Tower Health in Philadelphia, PA. His research focuses on the intersection of child safety and toxicology, including a statewide assessment of the association between child maltreatment and drug ingestion.

Marissa Hauptman, MD, MPH is a board-certified pediatrician, Co-Director of the Pediatric Environmental Health Center and the Region 1 New England Pediatric Environmental Health Specialty Unit, Associate Director of the Boston Children's Hospital Pediatric and Reproductive Environmental Health Fellowship Program, and Assistant Professor of Pediatrics at Harvard Medical School.

Dr. Hauptman’s research focuses on systematically integrating information about environmental exposures through environmental screening tools, spatial analysis techniques and biologic markers to improve environmental and social health disparities in children with chronic diseases. She recently was awarded an NIH/NIEHS K23 Career Development Award entitled, Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers.

Hannah Hays MD, FACEP, FAACT, FACMT, is an Associate Professor of Pediatrics and Emergency Medicine at The Ohio State University. She is the Chief of Toxicology at Nationwide Children’s Hospital, and the Medical Director of the Central Ohio Poison Center in Columbus, Ohio, USA, and is a member of the Board of Trustees for the American Academy of Clinical Toxicology. Dr. Hays is board certified in the emergency medicine, medical toxicology, and addiction medicine. Her advocacy work focuses on safe packaging of cannabis edibles to mitigate the impact of cannabis legalization on children under 6 years, regulation of delta-8 and other THC analogs to decrease child access and poisoning, and poison center involvement in toxicologic disaster response. Dr. Hays serves as the Guest Editor for the BioMed Central Public Health special collection on pediatric poisoning. Her research and clinical interests include the impact of emerging poisons on pediatric and adult health and poisoning self-harm attempts in preadolescent children.

Dr. Keahi Horowitz is an Emergency Medicine physician with a clinical focus in Medical Toxicology, serving as an Adjunct Assistant Professor in the School of Medicine. He earned his medical degree from the University of Hawaii, John A. Burns School of Medicine in 2019 and completed his Emergency Medicine residency at Stony Brook University in New York in 2022. Dr. Horowitz practices at the Oregon Poison Center, where he evaluates and manages a wide range of toxicologic emergencies and contributes to education and training in medical toxicology.

I am the Director of Clinical Toxicology at the Calvary Mater Newcastle, Professor at the University of Sydney and consultant toxicologist to the NSW Poisons Information Centre. I was made a Member of the Order of Australia in 2019 for my contribution to toxicology. I am President of the Asia Pacific Assocation of Medical Toxicologists, and a Board member of the EAPCCT. My major area of research is snake bite. I have published over 390 papers and received >$20 million in research funds. I have conducted 14 RCTs and coordinate or co-coordinate 5 large cohorts studies.

We are interested in studying the interaction of mitochondrial function in the area of acute care that includes sepsis and acute poisoning. We are currently taking a translational approach studying the mitochondria at a cell-based level, to various animal models, all the way to the clinical setting actively enrolling patients with these acute medical conditions with the goal to develop better prognostic measures with the potential for mitochondrial-directed therapy. 

Our lab has the latest models of the O2k-FluoRespirometer (O2k-Series H), Western blotting, confocal microscopy to study mitochondrial function in both in vitro and in vivo models with a focus on mitochondrial-directed therapies using substrate prodrugs. Relevant in vivo platforms include zebrafish, murine and porcine models of acute critical care illnesses that also combine state of the art physiological monitoring such as PV loop catheters providing realtime physiological data to be linked with cellular function. Our other interests also utilize the use of blood cells as proxy of organ cellular function as a type of biomarker which may provide prognostic function and allow clinicians to better gauge response to therapy. 

Combining these elements we aim to better understand the complex interactions of both bioenergetics in issues of acute care to better improve patient care and outcomes.

Dr. Thanjira Jiranantakan is specialized in public health, medical toxicology, internal medicine, addiction medicine, and occupational and environmental medicine. She has practiced in the US, Australia, and Thailand and has experience working with the WHO, the US Federal OSHA, government bodies, and NGOs. She is a senior staff specialist and researcher at Royal Prince Alfred Hospital, a Senior Clinical Lecturer at the University of Sydney, and a Medical Toxicologist and Public Health Advisor at the NSW Ministry of Health, Australia. Dr. Jiranantakan holds multiple leadership positions and serves on national and international committees. She is the President-Elect for the Asia Pacific Association of Medical Toxicology (APAMT). She has integrated practice in clinical service, policy and research. Her current focus is on recreational drug use, toxicosurveillance, early warning system, harm reduction, music festivals, drug checking, public health and occupational toxicology.

Katherine Katzung, MD is an attending physician in the emergency department at Abbott Northwestern, where she serves as chair of the department.  Additionally, she is the medical director of the hospital’s addiction medicine and toxicology program, which began in 2020 after she received grant funding to initiate a hospital-based toxicology/addiction medicine consult service as well as an  emergency department-based addiction medicine "bridge" clinic to provide continuity of care for patients initiated on Suboxone.  This innovative program allows patients evaluated at Abbott Northwestern in the emergency department or inpatient units continuity of care, while focusing on harm-reduction strategies, until they can be given a warm hand-off to community providers.

A graduate of the University of Minnesota School of Medicine, she completed emergency medicine training at Regions Hospital in St. Paul and additional fellowship training in medical toxicology.  She is board certified in emergency medicine, medical toxicology, and addiction medicine.  Her clinical interests surround the intersection of these 3 specialties, with special focus on early ED & hospital-based interventions to evaluate and treat substance use disorder, including initiation of medication assisted therapies.

She volunteers as a consultant for the Minnesota Poison Control System in addition to serving on the board of the Steve Rummler HOPE Network and acts as medical director of its overdose prevention program.

Born in 1975 and raised in Beirut, Lebanon, Dr. Kazzi trained in Emergency Medicine at Emory University in Atlanta (2000-03) where he served as a chief resident before completing a subspecialty fellowship in Medical Toxicology at Emory University, Georgia Poison Center and the Centers for Disease Control and Prevention (CDC) in Atlanta. He is board certified in both Emergency Medicine and Medical Toxicology. Dr. Kazzi joined the Department of Emergency Medicine at the University of Alabama at Birmingham (UAB) between 2005 and 2008 where he served as a Medical Toxicologist for the Regional Poison Control Center in Birmingham and the Alabama Poison Center. Currently, he is an associate professor at the department of Emergency Medicine at Emory University in Atlanta, Georgia as well as the director of the International Toxicology Postdoctoral Fellowship Program at Emory University (http://www.em.emory.edu/services/toxicology/international_postdoc_training.html). He is also the assistant medical director of the Georgia Poison Center (www.georgiapoisoncenter.org) and a medical toxicologist at the Radiation Studies Branch of the National Center for Environmental Health at the CDC (https://www.cdc.gov/nceh/radiation/) where he participates in emergency preparedness and response activities in radiation. As an emergency physician and toxicologist, Dr. Kazzi specializes in the recognition, triage, and management of poisonings and holds a deep interest in the areas of Radiation and International Toxicology. Over the past decade, he developed strong ties to India in the areas of medical toxicology, mass gathering medical preparedness, radiation emergency medicine, blast injuries and hazmat. Through his collaboration with the CDC, AIIMS, and PGIMER Chandigarh, he has delivered and co-directed the first Advanced Hazmat Life Support trainings in Ahmedabad and Delhi. He organized a number of training conferences in Nashik, Pune, Ujjain and Delhi and has been an invited speaker at the annual INDUS EM world congress. He is an active and founding board member of the Middle East North Africa Toxicology Association (www.menatox.org) and currently serves as its President. He is also a board member and chairs the International Committee of the American College of Medical Toxicology (www.acmt.net).

Dr. Emily Kiernan is an Assistant Professor at Emory University School of Medicine. She is a board-certified Emergency Medicine physician who recently completed a medical toxicology fellowship at Emory University/CDC. She has served as the fellow co-chair for the AACT Radiation Special Interest Section group as well as a chair in the ACMT Fellow-in-training association.

Michael J. Kosnett, MD, MPH, FACMT has 34 years of experience as a physician specializing in medical toxicology and occupational and environmental health. He is board certified in internal medicine, medical toxicology, and preventive medicine (occupational medicine). He has served in a leadership and advisory capacity to multiple national and international medical and public health organizations. This includes service as past president of the American College of Medical Toxicology and a member of the Committee on Toxicology of the National Academies of Sciences, Engineering, and Medicine and the Board of Scientific Counselors of the National Institute for Occupational Safety and Health. In addition, Dr. Kosnett has served as a consultant and temporary advisor to the World Health Organization; EPA Science Advisory Board expert panels; and advisory committees of the CDC National Center for Environmental Health and ATSDR. He has also served as a medical toxicology consultant to the US Army Public Health Command, the US Air Force Science Advisory Board, and the US Navy Naval Air Systems Command. In 2016, the American College of Medical Toxicology awarded Dr. Kosnett the Matthew J. Ellenhorn Award, a career achievement award that recognizes “extraordinary contributions to the field of medical toxicology.”

Dr. Patrick Kyle is a Professor of Pathology and the Director of the Clinical Chemistry, Special Chemistry, Serology and Toxicology laboratories at the University of Mississippi Medical Center. He is board certified as a Clinical Chemist (ABCC), Toxicological Chemist (ABCC), and Forensic Toxicology Specialist (ABFT). In addition to providing oversight to the laboratory, he also teaches medical students, dental students and Pathology residents. He is an international speaker, has authored over 50 peer-reviewed journal articles and book chapters, and serves as a reviewer for several scientific journals. His research interests include pharmaceutical toxicity, analytical method development, laboratory management and emerging biomarkers of disease.

Dr. Philip Landrigan is a pediatrician, public health physician, and internationally recognized leader in environmental health. He directs the Program for Global Public Health and the Common Good and the Global Observatory on Pollution and Health at Boston College. His groundbreaking research on lead and pesticide exposure established how these toxins harm children’s developing brains and informed U.S. policies that eliminated lead from gasoline and paint, dramatically reducing childhood lead poisoning.

Dr. Landrigan has led studies on the health impacts of 9/11 rescue work and chaired several global commissions, including the Lancet Commission on Pollution and Health and the Minderoo-Monaco Commission on Plastics and Human Health. His work continues to guide international efforts to prevent disease and protect human and planetary health. He is a member of the U.S. National Academy of Medicine.

Dr. Ophir Lavon is a board-certified medical toxicologist, clinical pharmacologist, and internal medicine specialist. He is the director of the Clinical Pharmacology and Toxicology Unit at Carmel Medical Center (Haifa, Israel), and leads its fellowship program. Dr. Lavon is the current chairperson of the Israeli Society for Clinical Pharmacology and the immediate past chair of the Israel Society of Toxicology (both affiliated with the Israel Medical Association). Dr. Lavon is a board member of the European Association of Poison Centres and Clinical Toxicologists (EAPCCT) and serves as the chairperson of its Communication Committee. He is an active member of ACMT and AACT. Dr. Lavon is a senior lecturer at the Rappaport Faculty of Medicine of the Technion – Israel Institution of Technology, Haifa, Israel. Dr. Lavon is the chair of several advisory committees for the Israel Ministry of Health, including the Advisory Committee for Preparedness and Response to Toxicological Mass Casualties Events and the National Committee for Antidotes. Dr. Lavon served for several years as a medical consultant at the Israel Poison Information Center, and he is the former director of the Patient Safety and Risk Management Unit at Carmel Medical Center.

Dr. Jacob Lebin is a board-certified emergency physician and medical toxicologist at the University of Colorado. He completed his medical degree at the University of Colorado School of Medicine, followed by an emergency medicine residency at the University of Washington and a fellowship in medical toxicology at the University of California, San Francisco.

His clinical time is split between the University of Colorado Hospital’s emergency department and the medical toxicology consultation service associated with the Rocky Mountain Poison Center. His research interests include best practices for the management of alcohol withdrawal and the use of clinical decision support for the treatment of alcohol and opioid use disorder."

Dr. Jennifer Love is an Assistant Professor of Emergency Medicine at The Mount Sinai Hospital and a physician-scientist whose work centers on the emergency care of patients with substance use disorders. As part of the Mount Sinai Center for Research on Emerging Substances, Poisoning, Overdose, and New Discoveries (RESPOND Center), she investigates novel adulterants in the opioid supply, including xylazine, and their clinical implications in emergency settings. Dr. Love is also deeply committed to advancing gender equity in medicine through education, advocacy, and research. She currently serves as Vice President of Education for the Academy for Women in Academic Emergency Medicine (AWAEM), leading national educational initiatives and workshops. Her published research has examined gender disparities in medical toxicology authorship, and her ongoing work explores representation in leadership across the field. Dr. Love earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania, where she also completed her residency and chief residency in emergency medicine, followed by a medical toxicology fellowship at Oregon Health & Science University and a T32 research fellowship at Mount Sinai. Outside of work, she enjoys cooking, ballet, and spending time with her family.

Bruno Mégarbane is Professor of critical care medicine at Paris University and directs a research team at INSERM UMRS-1144. He is the Head of the Department of Medical and Toxicological Critical Care at Lariboisière Hospital, Paris, France. He conducted several clinical and experimental studies in clinical toxicology.

Dr. Stacy Melanson is the Division Chief of Clinical Pathology at Mass General Brigham and an Associate Professor of Pathology at Harvard Medical School. Dr. Melanson has driven best practices for urine drug testing in urgent care settings and for compliance monitoring in patients on chronic opioid therapy for cancer or non-cancer related pain. She has published numerous articles on novel toxicology assays, optimal drug matrices and benefits of toxicology interpretations and has contributed to national guidelines for toxicology testing.

Dan McCabe, MD serves as Director of the Division of Medical Toxicology within the University of Iowa and as Medical Director of the Iowa Poison Control Center. His work focuses on clinical toxicology consultation services, systems improvement for poisoned patients, and statewide collaboration across public health and emergency response. He is board certified in emergency medicine, medical toxicology, and addiction medicine.

Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and drug-induced impairment.

Dr. Nicholas Nacca is the director of Medical Toxicology and Medical Toxicology Fellowship Director at the University of Rochester Medical Center. In addition to being faculty member in the Department of Emergency Medicine he holds a secondary appointment in the Department of Environmental Medicine. His primary role is staffing the educational and clinical medical toxicology consultation service, with educational responsibilities to medical toxicology fellows, multidisciplinary teams of medical residents, pharmacy residents and students, as well as medical students. He staffs and directs a referral based outpatient Medical Toxicology Clinic.

Dr. Phillips is a graduate of Texas A&M University, Class of 2007, with a Bachelor’s in Biomedical Science. He completed medical school at Texas Tech University School of Medicine in 2011 and attended the University of Pittsburgh for both residency in Emergency Medicine and fellowship in Medical Toxicology from 2011 – 2016. Following graduation, he accepted a position at John Peter Smith in Fort Worth, Texas where he served as their Assistant Program Director for the Emergency Medicine residency program and founded the inaugural Division of Medical Toxicology. Dr. Phillips then transitioned to University of Texas Southwestern in Dallas, Texas where he served as the Program Director of the Medical Toxicology Fellowship. Dr. Phillips is now serving as the Director of Toxicology for Integrative Emergency Services in Dallas/Fort Worth which is a private consulting group that covers 4 hospitals. His professional interests include medical education, medical toxicology advocacy, and alcohol withdrawal

Dr. Sessions practices serves as Interim Chair of Emergency Medicine and Chief of Medical Toxicology at Ochsner Medical Center - New Orleans. He also leads a Medication Assisted Treatment for Opioid Use Disorder expansion program for Ochsner Health Foundation. He completed a Medical Toxicology fellowship at the Rocky Mountain Poison & Drug Center at Denver Health in 2013. He is board-certified in Addiction Medicine by the American Board of Preventive Medicine. He is President-elect of the American College of Emergency Physicians Toxicology Section. He holds academic appointments at Xavier Ochsner College of Medicine and University of Queensland, Ochsner Clinical School.

Dr. Simpson is an emergency physician and medical toxicologist at Beth Israel Deaconess Medical Center and the Massachusetts & Rhode Island Poison Center. He completed his residency at Vanderbilt University Medical Center and his medical toxicology fellowship at the Harvard Medical Toxicology Fellowship. He is a current NHLBI T32 fellow with the Center for Resuscitation Science at BIDMC. His research focuses on risk stratification and resuscitation of cardiovascular toxicity in acute drug overdose.

Dr. Christine Snozek is director of clinical chemistry and point-of-care testing in the Department of Laboratory Medicine and Pathology at Mayo Clinic Arizona. She is a graduate of the Mayo School of Graduate Medical Education and has completed a fellowship in Clinical Chemistry at Mayo. Dr. Snozek’s interests include therapeutic drug monitoring, particularly transplant immunosuppression, toxicology testing and interpretation of results, and optimizing laboratory support of clinical practice.

Dr Joji Suzuki is a faculty within the Division of Addiction Treatment and Prevention, Psychiatry Department, Mass General Brigham, Brigham and Women’s Hospital (BWH), and an Associate Professor of Psychiatry at Harvard Medical School. He completed his medical training at Boston University School of Medicine, general psychiatry residency at Maine Medical Center, and addiction psychiatry fellowship at Boston Medical Center. He is board certified in Psychiatry, Addiction Psychiatry and Addiction Medicine, and is a member of the Motivational Interviewing Network of Trainers. He has successfully launched numerous treatment programs over the course of his career, including the comprehensive outpatient dual diagnosis addiction clinic at Brigham and Women’s Faulkner Hospital, and the low-barrier, low-threshold, harm-reduction Dushku Palandjian Bridge Clinic at BWH. He is the inaugural Program Director of the BWH Addiction Medicine Fellowship program. He has received NIH funding continuously since 2017 to conduct cutting edge clinical research. He is now a principal investigator on multiple NIH-funded clinical trials to evaluate treatments for substance use disorders, including the use of GLP-1 receptor agonists and psychedelic therapies.

Dr. Temple is an emergency medicine physician and medical toxicologist at Oregon Health & Science University and the Oregon Poison Center. She received her medical degree from the University of Massachusetts Medical School, completed her emergency medicine residency at the University of Massachusetts, and completed her Medical Toxicology Fellowship at Oregon Health & Science University. She is board-certified in emergency medicine and medical toxicology.

She serves as Assistant Program Director for the OHSU Medical Toxicology Fellowship and Assistant Medical Director of the Oregon Poison Center. She was the inaugural recipient of the ACMT Charles E. Becker Medal for outstanding achievement in medical toxicology. Her academic interests include emerging drugs of abuse, natural toxins, and innovative approaches to toxicology education.

Dr. Michael Toce completed his undergraduate studies at Carleton College where he received a B.A. in biology and biochemistry. He received a M.S. in bacteriology from the University of Wisconsin-Madison, and his M.D. from the Medical College of Wisconsin. He completed his pediatrics residency at the Boston Combined Residency Program before completing a Medical Toxicology Fellowship and Pediatric Emergency Medicine Fellowship at Boston Children's Hospital. He is currently an attending in the Boston Children's Hospital Emergency Department and works as a Medical Toxicologist at the MA/RI Poison Control Center. Dr. Michael Toce conducts research that focuses on pediatric toxicology and emergency medicine, with an emphasis on adolescent and young adult opioid exposures. He has published on the association of state opioid reduction policies (PDMPs, pain clinic legislation, naloxone access laws) with pediatric opioid poisonings and is currently focused on assessing the evolving relationship between youth mental health conditions and substance misuse.

David Toomey, MD earned his Doctor of Medicine degree from the University of Massachusetts Medical School and underwent residency training at the Harvard Affiliated Emergency Medicine Residency Program at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, Massachusetts. He completed his Fellowship in Medical Toxicology at the University of Rochester Medical Center in Rochester, NY where he currently serves as an Assistant Professor in the Department of Emergency Medicine and the division of Medical Toxicology.

James Watson is a board certified medical toxicologist and emergency medicine physician practicing at Maine Medical Center and the Northern New England Poison Center, and is an Assistant Professor in the Department of Emergency Medicine at Tufts University School of Medicine. James graduated from the University of Chicago Pritzker School of Medicine in 2017 before completing residency training at the Harvard Affiliated Emergency Medicine Residency at Beth Israel Deaconess Medical Center and fellowship training at the Harvard Medical Toxicology Program at Boston Children’s Hospital; both in Boston, Massachusetts. His academic interests include medical education, resource utilization within medical toxicology, and critical care toxicology. James is a Portland native, and lives in Southern Maine with his wife, son, and rescue dog Mowgli.

Dr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.

Dr. Stephanie Weiss is the Staff Research Physician serving the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011. She is board certified in addiction medicine and medical toxicology and participated in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA. Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the NIDA IRP mission of conducting inpatient and outpatient proof-of-concept human laboratory therapeutic and imaging studies for addictive disorders. Her research interests include GLP-1RAs, medication misuse, and improving interpretation of urine drug testing.

Caroline Wight is an Emergency Medicine physician and current fellow in training at Oregon Health and Science University and Oregon Poison Center. She earned her medical degree from Tufts University School of Medicine, Maine Track in 2022 and completed her Emergency Medicine residency at University of California Davis in Sacramento in 2025.

Dr. Jim Whitledge graduated from Tufts University School of Medicine, and subsequently completed a residency in emergency medicine at Beth Israel Deaconess Medical Center and fellowship training at the Harvard Medical Toxicology Fellowship. He is currently an emergency physician and medical toxicologist practicing within the University of Vermont Health Network. He enjoys taking call for the Northern New England Poison Center, and is also a consultant toxicologist for the Nepal Poison Information Center. Jim has a particular interest in drug and antidotal shortages, novel treatments for antimuscarinic delirium, pediatric toxicology, and treatment of substance use disorders. Jim spends his free time skiing, biking, and hiking with his family, and is excited when he finds mushrooms and owls in the woods.

Dr. Alan D. Woolf is a pediatrician and medical toxicologist. He is the Associate Chief Medical Education Officer at Boston Children’s Hospital and a Professor of Pediatrics at Harvard Medical School. He is Medical Director of the Pediatric Environmental Health Center at Boston Children’s Hospital, Director of the Pediatric Environmental Health Fellowship Training Program, and Principal Investigator of the Region 1 New England Pediatric Environmental Health Specialty Unit. He is currently a member of the Executive Committee of the American Academy of Pediatrics’ Council on Environmental Health & Climate Change and a member of the PFAS Subcommittee of the National PEHSU Program. Dr. Woolf has served as a consultant regarding PFAS water contamination to both the New Hampshire and Massachusetts Departments of Public Health since 2014. He co-authored one of the first papers to describe the PFAS water contamination event in Portsmouth NH and was a ‘Community Liaison’ giving input to the NASEM Report on PFAS published in 2022. He is currently a member of the New Hampshire State Advisory Committee on PFAS and cancer. 

Dr. Woolf is a past-president of both the American Academy of Clinical Toxicology and the American Association of Poison Control Centers. In 2018, Dr. Woolf received the Career Achievement Award from the AACT and, in 2019, he was named the Louis Roche Lecturer by the European Association of Poisons Centers and Clinical Toxicologists. He is the Editor of the recent book The History of Modern Clinical Toxicology published by Elsevier Publishers in 2021.